Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: A systematic review

Journal of Medical Screening

Volumn 14, Issue 3, 2007, Pages 132-137

  Burch, Jane A ^a   Soares Weiser, Karla ^b   St John, D James B ^c   Duffy, Steven ^a   Smith, Stephen ^d   Kleijnen, Jos ^e   Westwood, Marie ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Enhance Reviews   (Israel)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

^d UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^e KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL ADENOMA; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOCHEMISTRY; OCCULT BLOOD; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

COLORECTAL NEOPLASMS; DATABASES, FACTUAL; GUAIAC; HUMANS; IMMUNOCHEMISTRY; MASS SCREENING; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

EID: 34848842420     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/096914107782066220     Document Type: Article

References (100)

1. Strul H, Arber N. Fecal occult blood test for colorectal cancer screening. Ann Oncol 2002;13:51-6
2. Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJL. Cancer Incidence, Mortality and Survival by Site for 14 Regions of the World. Geneva: World Health Organization, 2001
3. National Statistics. Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2003, England Series MB1 no. 34. London: The Stationery Office, 2005
4. Bond JH. Fecal occult blood test screening for colorectal cancer. Gastrointest Endosc Clin N Am 2002;12:11-21
5. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71
6. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7
7. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71
8. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7
9. Walsh JM, Terdiman JP. Colorectal cancer screening: scientific review. JAMA 2003;289:1288-96
10. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale: update based on new evidence. Gastroenterology 2003;124:544-60
11. Young GP, St John DJ, Winawer SJ, Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002;97:2499-507
12. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper American College of Physicians. Ann Intern Med 1997;126:811-22
13. Walsh JM, Terdiman JP. Colorectal cancer screening: clinical applications. JAMA 2003;289:1297-302
14. Pearson SM. MDA evaluation of 11 faecal occult blood test kits. In: Martin SM, ed. Proceedings of Pathology. Birmingham, London: IBMS, 2000;114
15. NHS Centre for Reviews and Dissemination. Undertaking Systematic Reviews of Research on Effectiveness: CRD's Guidance for Those Carrying Out or Comissioning Reviews CDR Report 4. 2nd edn York: NHS Centre for Reviews and Dissemination, 2001
16. Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 2004;8:1-234
17. Honest H, Bachmann LM, Khan K. Electronic searching of the literature for systematic reviews of screening and diagnostic tests for preterm birth. Eur J Obstet Gynecol Reprod Biol 2003;107:19-23
18. Honest H, Khan KS. Reporting of measures of accuracy in systematic reviews of diagnostic literature. BMC Health Serv Res 2002;2:4
19. Smidt N, Rutjes AW, van der Windt DA, et al. Quality of reporting of diagnostic accuracy studies. Radiology 2005;235:347-53
20. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 2004;140:189-202
21. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002;21:1525- 37
22. Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323:157-62
23. Soares-Weiser K, Burch J, Duffy S, Smith S, Kleijnen J, Westwood M. Diagnostic accuracy and cost-effectiveness of faecal occult blood tests (FOBT) used in screening for colorectal cancer: a systematic review 2007. CRD Report 36. http://www.york.ac.uk/inst/crd/pdf/report36.pdf
24. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45
25. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
27. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value: long-term follow-up in a large group practice setting. Ann Intern Med 1990;112:328-33
28. Bang KM, Tillett S, Hoar SK, Blair A, McDougall V. Sensitivity of fecal hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening. J Occup Med 1986;28:709-13
29. Bennett DH, Hardcastle JD, Moshakis V, et al. A comparison of screening for colorectal cancer by flexible sigmoidoscopy and faecal occult blood testing (FOBT) with FOBT alone. Gastroenterology 1996;110:A491
30. Bhattacharya I, Sack EM. Screening colonoscopy is as effective as colonoscopy for a positive fecal occult blood test (FOBT) for the detection of colorectal neoplasia in average risk asymptomatic patients 60-75 years old. Gastroenterology 1997;112(4 Suppl):A538
31. Brevinge H, Lindholm E, Buntzen S, Kewenter J. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population. Int J Colorectal Dis 1997;12:291-5
32. Castiglione G, Grazzini G, Poli A, Bonardi R, Ciatto S. Hemoccult sensitivity estimate in a screening program for colorectal cancer in the Province of Florence. Tumori 1991;77:243-5
33. Collins JF, Lieberman DA, Durbin TE, Weiss DG. and the Veterans Affairs Cooperative Study #380 Group. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 2005;142:81-5
34. Foley DP, Dunne P, Dervan PJ, Callaghan TWO, Crowe J, Lennon JR. Left-sided colonoscopy and hemoccult screening for colorectal neoplasia. Eur J Gastroenterol Hepatol 1992;4:925-36
35. Klug W, Knoch HG. [What does the Krypto-Haem test accomplish in occult hemorrhage from the large intestine?] [in Japanese]. Z Arztl Fortbild (Jena) 1983;77:516-19
36. Lampe J, Jacobasch KH, Uhlig K. Krypto-haem SSWR, ein testbrief zum nachweis von okkultem blut im stuhl. Dtsch Gesundh Wes 1982;37:175-7
37. Launoy G, Smith TC, Duffy SW, Bouvier V. Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 1997;73:220-4
38. Lieberman DA, Weiss DG. For the Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-60
39. Mandel JS, Bond JH, Bradley M, et al. Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers: the University of Minnesota's Colon Cancer Control Study. Gastroenterology 1989;97:597-600
40. Michalek AM, Cummings KM, Gamble D. The use of a cancer registry in a mass screening program for colorectal cancer. Cancer Detect Prev 1988;11:353-7
41. Murakami R, Otani T, Nakanishi K, et al. Diagnostic validity of fecal occult blood tests for detecting gastroenterological cancers. Jpn J Cancer Res 1992;83:141-5
42. Niv Y, Lev-El M, Fraser G, Abuksis G, Tamir A. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut 2002;50:33-7
43. Parikh A, Ramamoorthy R, Kim KH, Holland BK, Houghton J. Fecal occult blood testing in a noncompliant inner city minority population: increased compliance and adherence to screening procedures without loss of test sensitivity using stool obtained at the time of in-office rectal examination. Am J Gastroenterol 2001;96:1908-13
44. Rasmussen M, Kronborg O, Fenger C, Jorgensen OD. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer: a randomized study. Scand J Gastroenterol 1999;34:73-8
45. Rennert G, Rennert HS, Miron E, Peterburg Y. Population colorectal cancer screening with fecal occult blood test. Cancer Epidemiol Biomarkers Prev 2001;10:1165-8
46. Ribet A, Frexinos J, Escourrou J, Delpu J. Occult blood tests and colorectal tumours. Lancet 1980;1:417
47. St John DJ, Young GP, McHutchison JG, Deacon MC, Alexeyeff MA. Comparison of the specificity and sensitivity of Hemoccult and Hemo-Quant in screening for colorectal neoplasia. Ann Intern Med 1992;117:376-82
48. Sung JJ, Chan FK, Leung WK, et al. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology 2003;124:608-14
49. Winawer SJ, Schottenfeld D, Miller D, et al. Detection of early colon cancer and colonic polyps. In: Nieburgs HE, ed. Prevention and Detection of Cancer: Proceedings of the Third International Symposium on Detection and Prevention of Cancer New York 1976, Part II, vol. 2. New York: Marcel Dekker, 1980;2103-10
50. Chen HS, Sheen-Chen SM. Influence of age and gender on surveillance for colorectal tumors in low-risk asymptomatic population. Anticancer Res 2002;22:399-403
51. Chen K, Jiao DA, Zheng S. et al. Diagnostic value of fecal occult blood testing for screening colorectal cancer. China Natl J New Gastroenterol 1997;3:166-8
52. Cheng TI, Wong JM, Hong CF, et al. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc 2002;101:685-90
53. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 2003;38:635-42
54. Itoh M, Takahashi K, Nishida H, Sakagami K, Okubo T. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme. J Med Screen 1996;3:66-71
55. Kawai K. Clinical study on MonoHaem, an immunological fecal occult blood test reagent. Nippon Daicho Komonbyo Gakkai Zasshi 1987;40:308-13
56. Kim YH, Kim J, Son HJ, et al. Immunochemical fecal occult blood test for detection of rectosigmoid cancer in asymptomatic adults. Gastroenterology 1998;114:A625
57. Liu HH, Huang TW, Chen HL, Wang TH, Lin JT. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy. Hepatogastroenterology 2003;50:1390-2
58. Morikawa T, Kato J, Yamaji Y, et al. Pitfall of immunological fecal occult blood test: a comparison with total colonoscopy. Gastrointest Endosc 2004;59:AB286
59. Nakama H, Fattah A, Zhang B, Uehara Y, Wang C. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps. Hepatogastroenterology 2000;47:386-9
60. Nakama H, Abdul Fattah AS, Zhang B, Kamijo N, Fujimori K, Miyata K. Detection rate of immunochemical fecal occult blood test for colorectal adenomatous polyps with severe dysplasia. J Gastroenterol 1997;32:492-5
61. Nakama H, Kamijo N, Fujimori K, Fattah AS, Zhang B. Diagnostic accuracy of immunochemical faecal occult blood test for gastric cancer. J Med Screen 1996;3:113-14
62. Nakama H, Zhang B, Kamijo N. Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas. Hepatogastroenterology 2004;51:1333-6
63. Nakama H, Zhang B, Fattah AA, Kamijo N, Zhang X. Characteristics of colorectal cancer that produce positive immunochemical occult blood test results on stool obtained by digital rectal examination. Can J Gastroenterol 2001;15:227-30
64. Nakama H, Zhang B, Fattah AS, Zhang X. Colorectal cancer in iron deficiency anemia with a positive result on immunochemical fecal occult blood. Int J Colorectal Dis 2000;15:271-4
65. Nakama H, Fattah AS, Zhang B, Kamijo N. Digital rectal examination sampling of stool is less predictive of significant colorectal pathology than stool passed spontaneously. Eur J Gastroenterol Hepatol 2000;12:1235-8
66. Nakama H, Zhang B, Abdul Fattah AS, Kamijo N, Fukazawa K. Relationships between a sign of rectal bleeding and the results of an immunochemical occult blood test, and colorectal cancer. Eur J Cancer Prev 2000;9:325-8
67. Nakama H, Kamijo N, Abdul Fattah AS, Zhang B. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study. J Med Screen 1996;3:63-5
68. Okamoto M, Kawabe T, Shiratori Y, et al. Risk for colorectal cancer in patients with positive fecal occult blood test: analysis on 5648 asymptomatic patients performed total colonoscopy. Gastroenterology 1997;112:A632
69. Tada M, Hosokawa N, Shimizu S, et al. Evaluation of a new fecal occult blood test. J Kyoto Prefectural Univ Med 1986;95:1331-7
70. Tada M. New immunological fecal occult blood test applying latex inhibition method]. Med Sci Pharmaceut 1988;20:1271-7
71. Zhang B, Nakama H, Fattah AS, Kamijo N. Lower specificity of occult-blood test on stool collected by digital rectal examination. Hepatogastroenterology 2002;49:165-7
72. Zhou DY, Feng FC, Zhang YL, et al. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening: analysis of a check-up of 6480 asymptomatic subjects. Chin Med J (Engl) 1993;106:739-42
73. Zhou PH, Zhang WZ. Experimental study on reverse passive hemagglutination for detection of human fecal occult blood. Natl Med J China 1987;67:671-2
74. Zhu WX, Lin JJ. Reverse passive hemagglutination for detection of fecal occult blood: a comparison with Japanese Immudia-Hem SP Kit. Chin Med J (Engl) 1988;101:519-22
75. Allison JE, Levin T, Sakoda L, et al. The new fecal occult blood tests have poor application sensitivity for significant polyps in average risk subjects. Gastroenterology 2002;122:A592-3
76. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996;334:155-9
77. Kikkawa N, Takeuchi H, Kawahara T, Okamoto M, Funahashi S, Yamamoto A. [Comparison of chemical and immunological methods in fecal occult blood testing] [in Japanese]. Gan No Rinsho 1987;33:1049-51
78. Matsuse R, Uchida K, Miyachi N, et al. [Immunochemical detection of fecal occult blood by latex-agglutination reaction for hemoglobin and transferrin]. Latest Med Sci 1989;44:2636-41
79. Miyoshi H, Ohshiba S, Asada S, Hirata I, Uchida K. Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests. Am J Gastroenterol 1992;87:67-73
80. Miyoshi H, Shimamoto C, Hirata I, et al. [The clinical study of the new immunological detection test (stick EIA) for faecal occult blood: first report]. Prog Med 1988;8:1510-2
81. Nakama H, Kamijo N. Accuracy of immunological fecal occult blood testing for colorectal cancer screening. Prev Med 1994;23:309-13
82. St John DJ, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993;104:1661-8
83. Takeshita T, Horiguchi J, Kinoshita T, et al. Immunological fecal occult blood testing with anti-human hemoglobin antibody]. Nippon Daicho Komonbyo Gakkai Zasshi 1985;38:369-75
84. Takeshita T, Sugimoto N, Ashizawa S. [Mass screening for colo-rectal cancer by fecal occult blood test]. Nippon Daicho Komonbyo Gakkai Zasshi 1982;35:561-6
85. Li S, Zhang C, Xu E. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms]. Zhonghua Zhong Liu Za Zhi 1995;17:381-3
86. Nakazato M, Yamano HO, Matsushita HO, et al. Immunologic fecal occult blood test for colorectal cancer screening. JMAJ 2006;49:203-7
87. Kutzner N, Hoffmann I, Linke C, et al. Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test. Cancer Lett 2005;229:33-41
88. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282:1061-6
89. Westwood ME, Whiting PF, Kleijnen J. How does study quality affect the results of a diagnostic meta-analysis? BMC Med Res Methodol 2005;5:20
90. Atkin WS. Impending or pending? The national bowel cancer screening programme. BMJ 2006;332; doi: 10.1136/bmj.38797.494757.47
91. Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem 2005;51:1335-41
92. Rutjes AW, Reitsma JB, Nisio MD, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. Can Med Assoc J 2006;174:469-76
93. Macrae FA, St John DJB. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982;82:891-8
94. Turunen MJ, Liewendahl K, Partanen P, Adlercreutz H. Immunological detection of faecal occult blood in colorectal cancer. Br J Cancer 1984;49:141-8
95. Macrae FA, St John DJ, Caligiore P, Taylor LS, Legge JW. Optimal dietary conditions for hemoccult testing. Gastroenterology 1982;82:899-903
96. Jaffe RM, Kasten B, Young DS, MacLowry JD. False negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 1975;83:824-6
97. Austoker J. Cancer prevention in primary care: screening for colorectal cancer. BMJ 1994;309:382-6
98. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003;49:1-6
99. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003;138:W1-2
100. Bossuyt PM, Reitsma JB. Standards for reporting of diagnostic accuracy. The STARD initiative. Lancet 2003;361:71